2018

2018

  1. Spitzer C, Otte C, … Wingenfeld K: The Dexamethasone Corticotropin Releasing Hormone test in healthy and depressed women with and without childhood adversity. Psychoneuroendocrinology 2018; 87: 147-151
     
  2. Euler S, Stalujanis E, Spitzer C: Aktueller Stand der Psychotherapie von Persönlichkeitsstörungen. ZPPP 2018; 66: 95-105
     
  3. Spitzer C, Masuhr O, Jaeger U, Euler S: Pseudogesunde: Eine Herausforderung für die psychotherapeutische Versorgung und empirische Psychotherapieforschung. Psychotherapeut 2018; 63: 483-90
     
  4. Cavedo E, Chiesa PA, Houot M, Ferretti MT, Grothe MJ, Teipel SJ, Lista S, Habert MO, Potier MC, Dubois B, Hampel H; INSIGHT-preAD Study Group; Alzheimer Predision Medicine Initiative (APMI). Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer’s disease in cognitively normal older adults with subjective memory complaints. Alzheimers Dement, 2018, 14(9): 1204-1215 (IF 14,42)
     
  5. Teipel SJ, Cavedo E, Hampel H, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative; Alzheimer Precision Medicine Initiative (APMI). Basal forebrain Volume, but not hippocampal volume, is a predictor of global cognitive decline in patients with Alzheimer’s disease treated with cholinesterase inhibitors. Front Neurol, 2018, 9:642 (IF 3,51)
     
  6. Grothe MJ, Sepulcre J, Gonzalez-Escamilla G, Jelistratova I, Schöll M, Hansson O, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. Molecular properties underlying regional vulnerability to Alzheimer’s disease pathology. Brain, 2018, 141(9):2755-2771 (IF 10,85)
     
  7. Thyrian JR, Hertel J, Schulze LN, Dörr M, Prüss H, Hempel P, Bimmler M, Kunze R, Grabe JH, Teipel SJ, Hoffmann W. Prevalence and Determinants of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients Screened Positive for Dementia: Results from the Population-Based DelpHi-Study. J Alzheimers Dis, 2018, 64(4):1091-1097 (IF 3,48)
     
  8. Wolf D, Tüscher O, Teipel SJ, Mierau A, Strüder H, Drzezga A, Baier B, Binder H, Fellgiebel A; German Age Gain study group. Mechanisms and modulators of cognitive training gain transfer in cognitively healthy aging: study protocol of the AgeGain study. Trials, 2018, 19(1):337 (IF 2,34)
     
  9. Teipel SJ, König A, Hey J, Kaye J, Krüger F, Robillard JM, Kirste T, Babiloni C. Use of nonintrusive sensor-based information and communication technology for real-world evidence for clinical trials in dementia. DADM, 2018, 14(9):1216-1231 (IF 0)
     
  10. Teipel SJ, Metzger C, Brosseron F, Buerger K, Brueggen K, Catak C, Diesing D, Dobisch L, Fließbach K, Franke C, Heneka MT, Kilimann I, Kofler B, Menne F, Peters O, Polcher A, Priller J, Schneider A, Spottke A, Spruth EJ, Thelen M, Thyrian RJ, Wagner M, Düzel E, Jessen F, Dyrba M; DELCODE study group. Multicenter resting state functional connectivity in prodromal and dementia stages of Alzheimer’s disease. J Alzheimers Dis, 2018, 64(3):801-813 (IF 3,48)
     
  11. Brueggen K, Dyrba M, Kilimann I, Henf J, Hoffmann W, Thyrian JR, Teipel SJ. Hippocampal mean diffusivity for the diagnosis of dementia and mild cognitive impairment in primary care. Curr Alzheimer Res, 2018, 15(11): 1005-1012 (IF 3,29)
     
  12. Strohmaier U, Keller F, Kilimann I, Michalowsky B, Wucherer D, Zwingmann I, Teipel SJ, Hoffmann W, Thyrian JR. Patients with dementia in primary care: Who is referred to a Neurologist/Psychiatrist and what patient-oriented factors are associated with the visit? J Alzheimers Dis, 2018, 64(3): 925-932 (IF 3,48)
     
  13. Teipel SJ, Cavedo E, Lista S, Habert MO, Potier MC, Grothe MJ, Epelbaum S, Sambati L, Gagliardi G, Toschi N, Greicius M, Dubois B, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Effect of Alzheimer’s disease risk and protective factors on cognitive trajectories in subjective memory complainers.  Alzheimers Dement., 2018, 14(9): 1126-1136 (IF 14,42)
     
  14. Buchert R, Lange C, Suppa P, Apostolova I, Spies L, Teipel SJ, Dubois B, Hampel H, Grothe MJ. Magnetic resonance imaging-based hippocampus volume for prediction of dementia in mild cognitive impairment: Why does the measurement method matter so little? Alzheimers Dement., 2018, 14(7): 976-978 (IF 14,42)
     
  15. Zwingmann I, Hoffmann W, Michalowsky B, Wucherer D, Eichler T, Teipel SJ, Dreier-Wolfgramm A, Kilimann I, Thyrian JR. Unmet needs of family dementia caregivers of persons with dementia: Primary medical care. Nervenarzt, 2018, 89(5): 495-499 (IF 0,87)
     
  16. Bohnen NI, Teipel SJ. Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes. Neurology, 2018, epub ahead of print (IF 8,32)
     
  17. Teipel SJ, Fritze T, Ellenrieder M, Haenisch B, Mittelmeier W, Doblhammer G. Association of joint replacement surgery with incident dementia diagnosis in German claims data. Int Psychogeriatr, 2018, 21:1-9 (IF 2,26)
     
  18. Bohnen NI, Grothe MJ, Ray NJ, Müller MLTM, Teipel SJ. Recent advances in cholinergic imaging and cognitive decline-Revisiting the cholinergic hypothesis of dementia. Curr Geriatr Rep, 2018, 7(1):1-11 (IF 0,77)
     
  19. Franzmeier N, Düzel E, Jessen F, Bürger K, Levin J, Duering M, Dichgans M, Haass C, Suárez-Calvet M, Fagan AM, Paumier K, Benzinger T, Masters CL, Morris JC, Perneczky R, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Teipel SJ, Kilimann I, Ramirez A, Rossor M, Jucker M, Chhatwal J, Spottke A, Boecker H, Brosseron F, Falkai P, Fliessbach K, Heneka MT, Laske C, Nestor P, Peters O, Fuentes Mi, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Kofler B, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÀ, Metzger C, Bittner D, Weiner M, Lee JH, Salloway S, Danek A, Goate A, Schofield PR, Bateman RJ, Ewers M. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease. Brain 2018, 141(4): 1186-1200 (IF 10,85)
     
  20. Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, Fliessbach K, Franke C, Fuentes M, Heneka MT, Jannowitz D, Kilimann I, Laske C, Menne F, Nestor P, Peters O, Priller J, Pross V, Ramirez A, Schneider A, Speck O, Spruth EJ, Teipel SJ, Vukovich R, Westerteicher C, Wilfang J, Wolfsgruber S, Wagner M, Düzel E. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE). Alzheimers Res Ther, 2018, 10(1): 15 (IF 6,21)
     
  21. Hampel H, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Melo Dos Santos A, Epelbaum S, Lamari F, Genthon R, Dubois B, Floris R, Garaci F, Lista S; Alzheimer Precision Medicine Initiative (APMI). Alzheimer’s disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aß 1-42, total-tau, phosphorylated-tau, NFL, neurogranin and YKL-40. Alzheimers Dement, 2018, epub ahead of print (IF 14,42)
     
  22. Ray NJ, Bradburn S, Murgatroyd C, Tosseeb U, Mir P, Lountouriotis GK, Teipel SJ, Grothe MJ. In vivo cholinergic basal forebrain atrophy predicts dognitive decline in de novo Parkinson’s disease. Brain, 2018, 141(1):165-176 (IF 10,85)
     
  23. Zwingmann I, Hoffmann W, Michalowsky B, Dreier-Wolfgramm A, Hertel J, Wucherer D, Eichler T, Kilimann I, Thiel F, Teipel SJ, Thyrian JR. Supporting family dementia caregivers: testing the efficacy of dementia care management on multifaceted caregivers’ burden. Aging Ment Health, 2018, (7): 889-896 (IF 2,66) 
     
  24. Teipel SJ, Kilimann I, Thyrian JR, Klöppel S, Hoffmann W. Potential role of neuroimaging markers for early diagnosis of dementia in primary care. Curr Alzheimer Res., 2018, 15(1): 18-27 (IF 3,29)
     
  25. Eichler T, Thyrian JR, Hertel J, Richter S, Michalowsky B, Wucherer D, Dreier A, Kilimann I, Teipel SJ, Hoffmann W. Patient Variables Associated with the Assignment of a Formal Dementia Diagnosis to Positively Screened Primary care Patients. Curr. Alzheimer Res., 2018, 15(1):44-50 (IF 3,29)
     
  26. Dyrba M, Grothe MJ, Mohammadi A, Binder H, Kirste T, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. Comparison of Different Hypotheses Regarding the Spread of Alzheimer’s Disease Using Markov Random Fields and Multimodal Imaging. J Alzheimers Dis, 2018, 65(3): 731-746 (IF 3,48)